Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Operating Expenses | 47,109 | 43,328 | 29,439 | 13,812 | 7,584 |
| Operating Income | -47,109 | -43,328 | -29,439 | -13,812 | -7,584 |
| Interest Expense | 0 | 112 | -559 | 16 | 229 |
| Other Income | 148 | 0 | 0 | 466 | 633 |
| Pre-tax Income | -46,961 | -43,440 | -28,880 | -13,362 | -7,180 |
| Income Tax | 638 | 103 | 29 | N/A | N/A |
| Net Income Continuous | -47,599 | -43,543 | -28,909 | -13,362 | -7,180 |
| Net Income | $-47,599 | $-43,543 | $-28,909 | $-13,362 | $-7,180 |
| EPS Basic Total Ops | -3,157.42 | -3,137.26 | -3,675.07 | -2,621.85 | -2,061.63 |
| EPS Basic Continuous Ops | -3,157.62 | -3,128.12 | -3,668.29 | -2,615.55 | -2,065.16 |
| EPS Diluted Total Ops | -3,157.42 | -3,137.26 | -3,675.07 | -2,621.85 | -2,061.63 |
| EPS Diluted Continuous Ops | -3,157.62 | -3,128.12 | -3,668.29 | -2,615.55 | -2,065.16 |
| EPS Diluted Before Non-Recurring Items | -2,442.58 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-46,255 | $-42,469 | $-28,610 | $-13,111 | $-6,838 |